Literature DB >> 4009023

Adriamycin-induced chronic proteinuria: a structural and functional study.

M P O'Donnell, L Michels, B Kasiske, L Raij, W F Keane.   

Abstract

Focal, segmental glomerulosclerosis is frequently associated with chronic proteinuria and progressively declining renal function in humans as well as in experimental models of glomerular disease. Although little is known regarding the pathogenesis of this lesion, persistent, massive proteinuria has been associated with a poor prognosis. The administration of adriamycin to rats results in proteinuria of glomerular origin. We used this model to study the glomerular functional and structural alterations associated with proteinuria of 4 to 5 weeks duration. Studies of single nephron function revealed a 34% reduction in nephron plasma flow and a 50% decline in the glomerular ultrafiltration coefficient in rats given adriamycin. Single nephron glomerular filtration rate, however, was only modestly reduced (27%), because of an 8.0 mm Hg elevation of mean transcapillary hydraulic pressure difference (P less than 0.05). Morphologically, glomeruli of adriamycin-treated rats demonstrated significantly increased mesangial matrix and cellularity. In addition, glomerular capillaries frequently appeared enlarged, and epithelial cell bleb formation was evident. Focal glomerulosclerosis, however, was only rarely seen. The functional and morphologic characteristics of chronic adriamycin nephrosis are different from those associated with chronic proteinuria induced by repetitive administration of aminonucleoside of puromycin. Comparison of the two models suggests that the development of focal glomerulosclerosis can be dissociated from proteinuria and elevations of intraglomerular hydraulic pressures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009023

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

Review 1.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

Review 2.  The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio A Brito-Melo; Cayo Antônio Soares de Almeida; Lázaro Lopes Moreira; Cleiton Willian Cordeiro; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

3.  Thirst and sodium appetite in rats with experimental nephrotic syndrome.

Authors:  Jie Xu; Alan Kim Johnson; Robert L Thunhorst
Journal:  Physiol Behav       Date:  2015-06-26

4.  Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.

Authors:  S Anderson; J R Diamond; M J Karnovsky; B M Brenner
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

5.  Interstitial nephritis induced by protein-overload proteinuria.

Authors:  A A Eddy
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

6.  The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varlakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

7.  Fibronectin expression in human mesangial cell cultures and its alterations by adriamycin.

Authors:  M Soose; S Wenzel; A Padur; D Oberst; H Stolte
Journal:  Cell Biol Toxicol       Date:  1995-02       Impact factor: 6.691

Review 8.  Glomerulosclerosis: are we any wiser?

Authors:  A M el Nahas
Journal:  Klin Wochenschr       Date:  1989-09-01

9.  Fibronectin turnover in human mesangial cell cultures as affected by adriamycin.

Authors:  M Soose; S Wenzel; H Stolte
Journal:  Cell Biol Toxicol       Date:  1993 Apr-Jun       Impact factor: 6.691

10.  RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.

Authors:  Jiancheng Guo; Radha Ananthakrishnan; Wu Qu; Yan Lu; Nina Reiniger; Shan Zeng; Wanchao Ma; Rosa Rosario; Shi Fang Yan; Ravichandran Ramasamy; Vivette D'Agati; Ann Marie Schmidt
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.